Overview

The American Urological Association will host its annual meeting at the Boston Convention Center in Boston, MA, from May 12-16, 2017.

Physicians and researchers from the Department of Urology at Massachusetts General Hospital will present on leading research and innovative approaches to treatment on topics including:

  • Consumer Reports in Endourology – What’s New?
  • First Penile Transplant in North America
  • Highlights of Urologic Oncology Research
  • Perioperative Opioid-Sparing Analgesia Strategies for Enhanced Recovery After Urologic Surgery
  • Prostate Cancer Update 2017
  • Take Home Messages: Infertility/Andrology

Follow us on Twitter with the hashtag #MGHAUA

View Mass General Presenters      View Presentations by Topic  

Urology at Mass General

SUBSCRIBE

Sign up to receive the latest news and advances from Mass General.

The Department of Urology is a leading provider of services for patients with any type of urological condition. Our comprehensive urological services provide leading-edge, patient-focused treatments, with our doctors performing more than 5,000 surgeries and procedures each year.

Contact Urology

  • Mass General Named Among Top Hospitals

    Massachusetts General Hospital has been consistently ranked as one of the top three hospitals in America by U.S. News & World Report and is the only hospital to be ranked across all 16 specialties.

    Learn More

Presentations

The complete Mass General AUA presentation listings by date are below.

Thursday, May 11, 2017

PresenterPresentation/
Poster Title
TimeSession Type
Aria Olumi, MD AUA Office of Research Update 4:40-4:55 p.m. Speaker

 

Friday, May 12, 2017

PresenterPresentation/
Poster Title
TimeSession Type
Michael L. Blute, MD Tumor Board: Kidney Cancer 10:20-10:50 a.m. Panelist
Jason Efstathiou, MD, DPhil Tumor Board: Bladder Cancer 9:55 - 10:20 a.m. Panelist
Brian Eisner, MD Consumer Reports in Endourology - What's New? 9:20 - 9:40 a.m. Speaker
Dicken S. C Ko, MD, FRCSC, FACS MP06: Transplantation & Vascular Surgery: Renal Transplantation & Vascular Surgery I 9:30 - 11:30 a.m. Poster Session Moderator
Dicken S. C Ko, MD, FRCSC, FACS 1st Penile Transplant in North America 10:05 - 10:15 a.m. Speaker
Richard Lee, MD, PhD Tumor Board: Bladder Cancer 9:55 - 10:20 a.m. Panelist
Kai Li, MD MP02-07: En-bloc Green Light 532nm Enucleation of Prostate (GLEP): First U.S. Experience 7 - 9:00 a.m. Moderated Poster
M. Dror Michaelson, MD, PhD Tumor Board: Kidney Cancer 10:20 - 10:50 a.m. Panelist
David Miyamoto, MD, PhD Molecular Characterization of Circulating Tumor Cells 2:20 - 2:35 p.m. Speaker
Aria Olumi, MD Welcome 8:00 - 8:05 a.m. Speaker
Sarah Mozafarpour, MD MP01-05: Can a stone obstructing the ureter cease to cause pain? 7-9:00 a.m. Moderated Poster
Ajay Singla, MD IAUA (Indian American Urological Association) Program (Aloft Boston Seaport Hotel, Mann Ballroom) 8 a.m.-1:30 p.m. Program Scientific Co-Chair
Ajay Singla, MD Female Pelvic Medicine and Reconstruction Session at the IAUA meeting 8:50-9:20 a.m. Moderator
Ajay Singla, MD Female Pelvic Floor Reconstruction Surgical Videos in BCEC room #254 9:30-11:30 a.m. Moderator
Matthew Smith, MD Tumor Board: Prostate Cancer 9-9:30 a.m. Panelist/Speaker
Cigdem Tanrikut, MD, FACS MP07: Infertility: Basic Research & Pathophysiology I 9:30-11:30 a.m. Moderator
Cigdem Tanrikut, MD, FACS Session 9 - ED in BPH Procedures & Diagnostic Testing in Sexual Medicine 5:10 - 6:00 p.m. Moderator
Ralph Weissleder, MD, PhD Imaging Drug Delivery 1:05-1:45 p.m. Keynote Speaker & Session Chair
Zongwei Wang, PhD MP17-07: Androgenic to Estrogenic Switch in Prostate Gland as a Result of Epigenetic Silencing of Steroid 5-α Reductase 2 3:30-5:30 p.m. Moderated Poster
Zongwei Wang, PhD MP17-16: Metformin Inhibits Benign Prostatic Epithelial Cells through Suppression of Insulin-like Growth Factor 1 Receptor 3:30-5:30 p.m. Moderated Poster

 

Saturday, May 13, 2017

PresenterPresentation/
Poster Title
TimeSession Type
Brian Eisner, MD PD16 - Stone Disease: Surgical Therapy I 7-9:00 a.m. Podium Session Moderator
Brian Eisner, MD 024IC - Pesadillas en Endourología (este curso se presenta sólo en español) 10 a.m. - 12 p.m. Course Faculty
Nawar Hanna, MD MP38-19: Multiparametric MRI/Ultrasound Fusion Biopsy Improves But Does Not Replace Standard Template Biopsy for the Detection of Prostate Cancer 1-3:00 p.m. Moderated Poster
Dicken S. C Ko, MD, FRCSC, FACS MP30-01: Penis Transplantation: First U.S. Experience 9:30-11:30 a.m. Moderated Poster
Sarah Mozafarpour, MD MP31-08: Is Osteoporosis an Independent Risk Factor for Urinary Incontinence? Results from the National Health and Nutrition Examination Survey 9:30-11:30 a.m. Moderated Poster
Michael Ursiny, MD PD16-03: A Decision Analysis Model of Observation vs. Immediate Re-Intervention for Asymptomatic Residual Fragments - 4mm Following Ureteroscopic Lithotripsy (A Study from the EDGE Consortium) 7:20-7:30 a.m. Podium
Anton Wintner, MD MP23-18: Synergistic Photodynamic Therapy for Catheter-Associated Urinary Tract Infection in Rats 7 - 9:00 a.m. Moderated Poster

 

Sunday, May 14, 2017

PresenterPresentation/
Poster Title
TimeSession Type
Michael L. Blute, MD MP55: Kidney Cancer: Localized: Surgical Therapy III 9:30-11:30 a.m. Poster Session Moderator
Jason Efstathiou, MD, DPhil International Prostate Forum: THE BEST OF BOSTON! 3:15-4:15 p.m. Speaker
Brian Eisner, MD MP50-16 - Initial Clinical Experience with a Single-use Digital Flexible Ureteroscope 9:30-11:30 a.m. Moderated Poster
Francis J. McGovern, MD 060IC: Perioperative Opioid-Sparing Analgesia Strategies for Enhanced Recovery After Urologic Surgery 4-6:00 p.m. Course Faculty
Aria Olumi, MD Welcome Remarks 8-8:05 a.m. Speaker
Alberto Pieretti, MD PD36-12: Comparing Complications and Survival of Primary Cystectomy vs. Salavage Cystectomy after Trimodal Therapy 8:50 - 9:00 a.m. Podium
Meike Schneider, MD Folliculin Tumor Suppressor Binds to Translation Initiation Factors EIF2G & EIF5B and Suppresses Protein Synthesis 1 - 3:00 p.m. Moderated Poster
Matthew Smith, MD, PhD International Prostate Forum: THE BEST OF BOSTON! 3:15-4:15 p.m. Speaker
Shahin Tabatabaei, MD Surgical Techniques: Benign Prostatic Hyperplasia (BPH) 9-10:30 a.m. Surgeon

 

Monday, May 15, 2017

PresenterPresentation/
Poster Title
TimeSession Type
Douglas M. Dahl, MD 068IC - Prostate Cancer Update 2017 (traducido en español) 7:30-9:30 a.m. Course Faculty
Michelle Kim, MD, PhD PD50-07: Low Serum Testosterone is Associated with Increased Stress and Mixed Incontinence in Women 8-8:10 a.m. Podium
Ross Krasnow, MD PD58-01: Validation of Venous Thromboembolism Risk Assessment Score in Major Urologic Cancer Surgery: A Population-Based Study 1-1:10 p.m. Podium
Aria Olumi, MD Highlights of Urologic Oncology Research 8-8:15 a.m. Presenter
Aria Olumi, MD Plenary Prime Time 1-4:30 p.m. Moderator
Keyan Salari, MD, PhD PD55-03: Active Surveillance for Low-risk Prostate Cancer in Men Under 60 Years of Age 9:50-10 a.m. Podium
Keyan Salari, MD, PhD PD55-05: Active Surveillance is a Viable Option for Men with Borderline Low-risk Prostate Cancer 10:10-10:20 a.m. Podium

 

Tuesday, May 16, 2017

PresenterPresentation/
Poster Title
TimeSession Type
Jason Efstathiou, MD, DPhil PD72: Prostate Cancer: Localized: Radiation Therapy II 9:30 - 11:30 a.m. Moderator - Podium
Brian Eisner, MD 091IC - Urolithiasis: Metabolic Evaluation and Medical Treatment 7:30-9:30 a.m. Course Faculty
Brian Eisner, MD Complex Cases: Stones 9:30-10 a.m. Panelist
Brian Eisner, MD 093IC - Supine vs. Prone Percutaneous Nephrolithotomy: Patient Selection, Positioning and Direct Vision Percutaneous Renal Access. Safer, Faster, Easier. 10 a.m.-12 p.m. Course Faculty
Adam S. Feldman, MD, MPH PD65: Prostate Cancer Markers II 7-9 a.m. Podium Session Moderator
Sarah Prophet, BA, and Adam S. Feldman, MD, MPH PD65-05: Urine expression of TIMP1, serpinB1, and semenogelin 2 may differentiate men with low-risk or no evidence of prostate cancer from men with high-risk or metastatic disease 7:40-7:50 a.m. Podium
Nawar Hanna, MD PD67-09: Comparative Effectiveness of Robot-assisted vs. Open Radical Cystectomy 8:20-8:30 a.m. Podium
Dicken S. C Ko, MD, FRCSC, FACS Complex Cases: Malignancy in Transplant Patients 8:50-9:10 a.m. Panelist
Cigdem Tanrikut, MD, FACS Take Home Messages: Infertility/Andrology 2-2:10 p.m. Presenter
Chin-Lee Wu, MD, PhD PD73: Kidney Cancer: Localized: Surgical Therapy VII 9:30 - 11:30 a.m. Moderator - Podium

Presenters

Mass General physicians and researchers presenting at AUA 2017:

  • Michael Blute, MD

    Chief, Department of Urology

    Panelist, Tumor Board: Kidney Cancer (Friday, May 12, 10:20 - 10:50 a.m.)

    Poster Session Moderator, MP55: Kidney Cancer: Localized: Surgical Therapy III (Sunday, May 14, 9:30 - 11:30 a.m.)

  • Douglas Dahl, MD

    Chief, Division of Urologic Oncology

    Course Faculty, 068IC - Prostate Cancer Update 2017 (traducido en español) (Monday, May 15, 7:30 - 9:30 a.m.)

  • Jason Efstathiou, MD, DPhil

    Director, Genitourinary Division, Department of Radiation Oncology

    Panelist, Tumor Board: Bladder Cancer (Friday, May 12, 9:55 - 10:20 a.m.)

    Speaker, International Prostate Forum: THE BEST OF BOSTON! (Sunday, May 14, 3:15 - 4:15 p.m.)

    Moderator - Podium, PD72: Prostate Cancer: Localized: Radiation Therapy II (Tuesday, May 16, 9:30 - 11:30 a.m.)

  • Brian Eisner, MD

    Co-Director, Kidney Stone Program

    Speaker, Consumer Reports in Endourology - What's New? (Friday, May 12, 9:20 - 9:40 a.m.)

    Podium Session Moderator, PD16 - Stone Disease: Surgical Therapy I (Saturday, May 13, 7 - 9:00 a.m.)

    Course Faculty, 024IC - Pesadillas en Endourología (este curso se presenta sólo en español) (Saturday, May 13, 10:00 a.m. - 12:00 p.m.)

    Moderated Poster, MP50-16 - Initial clinical experience with a single-use digital flexible ureteroscope (Sunday, May 14, 9:30 - 11:30 a.m.)

    Course Faculty, 091IC - Urolithiasis: Metabolic Evaluation and Medical Treatment (Tuesday, May 16, 7:30 - 9:30 a.m.)

    Panelist, Complex Cases: Stones (Tuesday, May 16, 9:30 - 10:00 a.m.)

    Course Faculty, 093IC - Supine vs. Prone Percutaneous Nephrolithotomy: Patient Selection, Positioning and Direct Vision Percutaneous Renal Access. Safer, Faster, Easier. (Tuesday, May 16, 10 a.m. - 12:00 p.m.)

  • Adam S. Feldman, MD, MPH

    Director, Combined Harvard Urologic Oncology Fellowship

    Podium Session Moderator, PD20 - Kidney Cancer: Localized: Surgical Therapy I (Saturday, May 13, 7 - 9:00 a.m.)

  • Nawar Hanna, MD

    Urologic Oncology Fellow (Mass General and Brigham and Women's Hospital)

    Moderated Poster, MP38-19: Multiparametric MRI/Ultrasound Fusion Biopsy Improves but does not Replace Standard Template Biopsy for the Detection of Prostate Cancer (Saturday, May 13, 1 - 3:00 p.m.)

    Podium, PD67-09: Comparative Effectiveness of Robot-Assisted vs. Open Radical Cystectomy (Tuesday, May 16, 8:20 - 8:30 a.m.)

  • Michelle Kim, MD, PhD

    Harvard Urologic Surgery Residency Program

    Podium, PD50-07: Low Serum Testosterone Is Associated with Increased Stress and Mixed Incontinence in Women (Monday, May 15, 8 - 8:10 a.m.)

  • Dicken S. C Ko, MD, FRCSC, FACS

    Director, Urology Regional Program

    Poster Session Moderator, MP06: Transplantation & Vascular Surgery: Renal Transplantation & Vascular Surgery I (Friday, May 12, 9:30 - 11:30 a.m.)

    Speaker, 1st Penile Transplant in North America (Friday, May 12, 10:05 - 10:15 a.m.)

    Moderated Poster, MP30-01: Penis Transplantation: First U.S. Experience (Saturday, May 13, 9:30 - 11:30 a.m.)

    Panelist, Complex Cases: Malignancy in Transplant Patients (Tuesday, May 16, 8:50 - 9:10 a.m.)

  • Ross Krasnow, MD

    Urologic Oncology Fellow (Mass General and Brigham and Women's Hospital)

    Podium, PD58-01: Validation of Venous Thromboembolism Risk Assessment Score in Major Urologic Cancer Surgery: A Population Based Study (Monday, May 15, 1- 1:10 p.m.)

  • Richard JaeBong Lee, MD, PhD

    Panelist, Tumor Board: Kidney Cancer (Friday, May 12, 9:55 - 10:20 a.m.)

  • Kai Li, MD

    Harvard Urologic Surgery Residency Program

    MP02-07: En-bloc Green Light 532nm Enucleation of Prostate (GLEP): First U.S. Experience (7 - 9:00 a.m., Friday, May 12)

  • Francis J. McGovern, MD

    Course Faculty, 060IC: Perioperative Opioid-Sparing Analgesia Strategies for Enhanced Recovery After Urologic Surgery (Sunday, May 14, 4 - 6:00 p.m.)

  • M. Dror Michaelson, MD, PhD

    Panelist, Tumor Board: Kidney Cancer (Friday, May 12, 10:20 - 10:50 a.m.)

  • David Miyamoto, MD, PhD

    Speaker, Molecular Characterization of Circulating Tumor Cells (Friday, May 12, 2:20 - 2:35 p.m.)

  • Sarah Mozafarpour, MD

    Postdoctoral Research Fellow

    Moderated Poster, MP01-05: Can a stone obstructing the ureter cease to cause pain? (Friday, May 12, 7 - 9:00 a.m.)

    Moderated Poster, MP31-08: Is Osteoporosis an Independent Risk Factor for Urinary Incontinence? Results from the National Health and Nutrition Examination Survey (Saturday, May 13, 9:30 - 11:30 a.m.)

  • Aria Olumi, MD

    Director, Urology Research

    Urology Residency Program Director

    Co-Director, GU Oncology Clinical Program

    Speaker, AUA Office of Research Update (Thursday, May 11, 4:40 - 4:55 p.m.)

    Speaker, Welcome (Friday, May 12, 8 - 8:05 a.m.)

    Speaker, Welcome Remarks (Sunday, May 14, 8 - 8:05 a.m.)

    Presenter, Highlights of Urologic Oncology Research (Monday, May 15, 8 - 8:15 a.m.)

    Moderator, Plenary Prime Time (Monday, May 15, 1 - 4:30 p.m.)

  • Alberto Pieretti, MD

    Harvard Urologic Surgery Residency Program

    Moderated Poster, PD36-12: Comparing complications and survival of primary cystectomy vs. salvage cystectomy after Trimodal Therapy (Sunday, May 14, 8:50 - 9:00 a.m.)

  • Keyan Salari, MD, PhD

    Harvard Urologic Surgery Residency Program

    Podium, PD55-03: Active surveillance for low-risk prostate cancer in men under 60 years of age (Monday, May 15, 9:50 - 10:00 a.m.)

    Podium, PD55-05: Active surveillance is a viable option for men with borderline low-risk prostate cancer (Monday, May 15, 10:10 - 10:20 a.m.)

  • Meike Schneider, MD

    Research Fellow in Medicine

    Folliculin Tumor Suppressor Binds to Translation Initiation Factors EIF2G & EIF5B and Suppresses Protein Synthesis (Sunday, May 14, 1 - 3:00 p.m.)

  • Ajay Singla, MD

    Program Scientific Co-Chair, IAUA (Indian American Urological Association) Program (Friday, May 12, 8 a.m. - 1:30 p.m., Aloft Boston Seaport Hotel, Mann Ballroom)

    Moderator, Female Pelvic Medicine and Reconstruction Session at the IAUA meeting (Friday, May 12, 8:50 - 9:20 a.m.)

    Moderator, Female Pelvic Floor Reconstruction Surgical Videos (Friday, May 12, 9:30 - 11:30 a.m. in BCEC room #254)

  • Matthew R. Smith, MD, PhD

    Panelist/Speaker, Tumor Board: Prostate Cancer (Friday, May 12, 9 - 9:30 a.m.)

    Speaker, International Prostate Forum: THE BEST OF BOSTON! (Sunday, May 14, 3:15 - 4: 15 p.m.)

  • Shahin Tabatabaei, MD

    Surgeon, Surgical Techniques: Benign Prostatic Hyperplasia (BPH) (Sunday, May 14, 9 - 10:30 a.m.)

  • Cigdem Tanrikut, MD, FACS

    Director, Male Reproductive Medicine

    Moderator, MP07: Infertility: Basic Research & Pathophysiology I (Friday, May 12, 9:30 - 11:30 a.m.)

    Moderator, Session 9 – ED in BPH Procedures & Diagnostic Testing in Sexual Medicine (Friday, May 12, 5:10 - 6:00 p.m.)

    Presenter, Take Home Messages: Infertility/Andrology (Tuesday, May 16, 2 - 2:10 p.m.)

  • Michal Ursiny, MD

    Harvard Urologic Surgery Residency Program

    Podium, PD16-03: A decision analysis model of observation vs. immediate re-Intervention for asymptomatic residual fragments < 4mm following Ureteroscopic lithotripsy: a study from the EDGE Consortium (Saturday, May 13, 7:20 - 7:30 a.m.)

  • Ralph Weissleder, MD, PhD

    Director, Center for Molecular Imaging Research

    Keynote Speaker & Session Chair, Imaging Drug Delivery (Friday, May 12, 1:05 - 1:45 p.m.)

  • Zongwei Wang, PhD

    Moderated Poster, MP17-07: Androgenic to Estrogenic Switch in Prostate Gland as a Result of Epigenetic Silencing of Steroid 5-α Reductase 2 (Friday, May 12, 3:30 - 5:30 p.m.)

    MP17-16: Metformin inhibits benign prostatic epithelial cells through suppression of Insulin-like growth factor 1 receptor (Friday, May 12, 3:30 - 5:30 p.m.)

  • Anton Wintner, MD

    Harvard Urologic Surgery Residency Program

    Moderated Poster, MP23-18: Synergistic Photodynamic Therapy for Catheter-Associated Urinary Tract Infection in Rats (7 - 9:00 a.m., Saturday, May 13)

  • Chin-Lee Wu, MD, PhD

    Associate Pathologist, Massachusetts General Hospital

    Moderator - Podium, PD73: Kidney Cancer: Localized: Surgical Therapy VII (Tuesday, May 16, 9:30 - 11:30 a.m.)

Highlights

Back to Top